Parkinson's Disease Therapeutics Market Analysis, Size, Share, Growth, Trends, and Forecast 2021 - 2028

                                                                        
Parkinson's disease is a neurological disorder that progresses due to the degeneration of motor neurons in the brain.

  Parkinson's Disease Therapeutics Market


Parkinson's disease is a neurological disorder that progresses due to the degeneration of motor neurons in the brain. It is distinguished by rigidity, tremors, walking difficulty, motor impairment, depression, and dementia. Medication, supportive therapies, and surgical procedures such as deep brain stimulation are some of the common treatment options for this disorder. Carbidopa-levodopa medications, dopamine agonists, monoamine oxidase B (MAO B) inhibitors, catechol O-methyltransferase (COMT) inhibitors, and anticholinergics are among the medications available. These treatment methods are extremely effective in managing Parkinson's disease symptoms and providing comfort to the patient in the event of a seizure.

Parkinson's disease prevalence and an ageing population are expected to drive the Parkinson's Disease Treatment Market in the coming years. In addition, government funding for research and widespread use of L-Dopa, a symptomatic dopamine replacement treatment and nigrostriatal system, is expected to boost the market in the coming years. Furthermore, the shift in research activities from symptomatic treatment to Parkinson disease modifying treatment will open up lucrative growth opportunities for the Parkinson's disease treatment industry in the coming years. There are certain constraints and challenges that can stymie market growth. The availability of alternatives is likely to act as a market restraint.


Market Segmentation:

By Drug Class

  • Levodopa
  • Dopamine agonists
  • MAO-B inhibitors
  • Anticholinergics
  • Others
By Route of Administration
  • Oral
  • Injectable
  • Nasal
  • Transdermal
  • Others

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Men were found to have a higher incidence, with the risk being approximately 1.5 times greater in men than in women. It is most common in people over the age of 60. Medications and other forms of therapy, such as exercise, can help alleviate some of the symptoms of Parkinson's disease. Medications such as levodopa, safinamide, pramipexole, benztropine, and selegiline are important therapeutic options for Parkinson's disease patients.

The major players operating in the global Parkinson’s disease therapeutic market include Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline Plc., AbbVie Inc., Merck & Co., Inc., Zydus Cadila, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries Ltd., Cipla Inc., and Boehringer Ingelheim International GmbH.

Comments

Popular posts from this blog

Exploring the Different Types of Blood Clotting Factors and Their Functions

Aromatherapy Market: A Scent-Sational Journey to Wellness and Market Growth

Molecular Sieves Catalyst Market: Global Company Analysis and Forecast 2018 – 2026 | Albemarle Corporation, W. R. Grace and Company, Silkem Ltd., Sinopec Group, and JGC Catalysts & Chemicals Ltd.